메뉴 건너뛰기




Volumn 32, Issue 36, 2015, Pages 4155-4161

Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN PATCHED 1; CELL SURFACE RECEPTOR; PATCHED RECEPTORS; REPRESSOR PROTEIN; SUFU PROTEIN, HUMAN;

EID: 84919767719     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.2569     Document Type: Article
Times cited : (215)

References (39)
  • 1
    • 0027231001 scopus 로고
    • Complications of the naevoid basal cell carcinoma syndrome: Results of a population based study
    • Evans DG, Ladusans EJ, Rimmer S, et al: Complications of the naevoid basal cell carcinoma syndrome: Results of a population based study. J Med Genet 30:460-464, 1993
    • (1993) J Med Genet , vol.30 , pp. 460-464
    • Evans, D.G.1    Ladusans, E.J.2    Rimmer, S.3
  • 2
    • 0031002840 scopus 로고    scopus 로고
    • Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome
    • Kimonis VE, Goldstein AM, Pastakia B, et al: Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69:299-308, 1997
    • (1997) Am J Med Genet , vol.69 , pp. 299-308
    • Kimonis, V.E.1    Goldstein, A.M.2    Pastakia, B.3
  • 3
    • 0028271569 scopus 로고
    • Nevoid basal cell carcinoma syndrome: Review of 118 affected individuals
    • Shanley S, Ratcliffe J, Hockey A, et al: Nevoid basal cell carcinoma syndrome: Review of 118 affected individuals. Am J Med Genet 50:282-290, 1994
    • (1994) Am J Med Genet , vol.50 , pp. 282-290
    • Shanley, S.1    Ratcliffe, J.2    Hockey, A.3
  • 4
    • 0026043909 scopus 로고
    • The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma
    • Evans DG, Farndon PA, Burnell LD, et al: The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64:959-961, 1991
    • (1991) Br J Cancer , vol.64 , pp. 959-961
    • Evans, D.G.1    Farndon, P.A.2    Burnell, L.D.3
  • 5
    • 0030913738 scopus 로고    scopus 로고
    • The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma
    • Cowan R, Hoban P, Kelsey A, et al: The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer 76:141-145, 1997
    • (1997) Br J Cancer , vol.76 , pp. 141-145
    • Cowan, R.1    Hoban, P.2    Kelsey, A.3
  • 6
    • 0026602737 scopus 로고
    • Location of gene for Gorlin syndrome
    • Farndon PA, Del Mastro RG, Evans DG, et al: Location of gene for Gorlin syndrome. Lancet 339: 581-582, 1992
    • (1992) Lancet , vol.339 , pp. 581-582
    • Farndon, P.A.1    Del Mastro, R.G.2    Evans, D.G.3
  • 7
    • 15844386165 scopus 로고    scopus 로고
    • Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome
    • Hahn H, Wicking C, Zaphiropoulous PG, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851, 1996
    • (1996) Cell , vol.85 , pp. 841-851
    • Hahn, H.1    Wicking, C.2    Zaphiropoulous, P.G.3
  • 8
    • 28644451209 scopus 로고    scopus 로고
    • Clinical testing for the nevoid basal cell carcinoma syndrome in a DNA diagnostic laboratory
    • Klein RD, Dykas DJ, Bale AE: Clinical testing for the nevoid basal cell carcinoma syndrome in a DNA diagnostic laboratory. Genet Med 7:611-619, 2005
    • (2005) Genet Med , vol.7 , pp. 611-619
    • Klein, R.D.1    Dykas, D.J.2    Bale, A.E.3
  • 9
    • 33746718114 scopus 로고    scopus 로고
    • DHPLC analysis of patients with nevoid basal cell carcinoma syndrome reveals novel PTCH missense mutations in the sterol-sensing domain
    • Marsh A, Wicking C, Wainwright B, et al: DHPLC analysis of patients with nevoid basal cell carcinoma syndrome reveals novel PTCH missense mutations in the sterol-sensing domain. Hum Mutat 26:283, 2005
    • (2005) Hum Mutat , vol.26 , pp. 283
    • Marsh, A.1    Wicking, C.2    Wainwright, B.3
  • 10
    • 33747162695 scopus 로고    scopus 로고
    • PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: A French study
    • Soufir N, Gerard B, Portela M, et al: PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: A French study. Br J Cancer 95:548-553, 2006
    • (2006) Br J Cancer , vol.95 , pp. 548-553
    • Soufir, N.1    Gerard, B.2    Portela, M.3
  • 11
    • 12844276949 scopus 로고    scopus 로고
    • Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident
    • Wicking C, Shanley S, Smyth I, et al: Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 60:21-26, 1997
    • (1997) Am J Hum Genet , vol.60 , pp. 21-26
    • Wicking, C.1    Shanley, S.2    Smyth, I.3
  • 12
    • 79955437939 scopus 로고    scopus 로고
    • Basal cell carcinomas in Gorlin syndrome: A review of 202 patients
    • Jones EA, Sajid MI, Shenton A, et al: Basal cell carcinomas in Gorlin syndrome: A review of 202 patients. J Skin Cancer 2011:217378, 2011
    • (2011) J Skin Cancer , vol.2011 , pp. 217378
    • Jones, E.A.1    Sajid, M.I.2    Shenton, A.3
  • 13
    • 84907169371 scopus 로고    scopus 로고
    • Intronic splicing mutations in PTCH1 cause Gorlin syndrome
    • epub ahead of print on March 22
    • Bholah Z, Smith MJ, Byers HJ, et al: Intronic splicing mutations in PTCH1 cause Gorlin syndrome. Fam Cancer [epub ahead of print on March 22, 2014]
    • (2014) Fam Cancer
    • Bholah, Z.1    Smith, M.J.2    Byers, H.J.3
  • 14
    • 78649565715 scopus 로고    scopus 로고
    • Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds
    • Bauer P, Stevanin G, Beetz C, et al: Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds. J Neurol Neurosurg Psychiatry 81:1229-1232, 2010
    • (2010) J Neurol Neurosurg Psychiatry , vol.81 , pp. 1229-1232
    • Bauer, P.1    Stevanin, G.2    Beetz, C.3
  • 15
    • 33845696394 scopus 로고    scopus 로고
    • High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia
    • Beetz C, Nygren AO, Schickel J, et al: High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 67:1926-1930, 2006
    • (2006) Neurology , vol.67 , pp. 1926-1930
    • Beetz, C.1    Nygren, A.O.2    Schickel, J.3
  • 16
    • 84870410019 scopus 로고    scopus 로고
    • Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation
    • Kijima C, Miyashita T, Suzuki M, et al: Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Fam Cancer 11:565-570, 2012
    • (2012) Fam Cancer , vol.11 , pp. 565-570
    • Kijima, C.1    Miyashita, T.2    Suzuki, M.3
  • 17
    • 3543023204 scopus 로고    scopus 로고
    • Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
    • Schouten JP, McElgunn CJ, Waaijer R, et al: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57, 2002
    • (2002) Nucleic Acids Res , vol.30 , pp. e57
    • Schouten, J.P.1    McElgunn, C.J.2    Waaijer, R.3
  • 18
    • 0036648241 scopus 로고    scopus 로고
    • Mutations in SUFU predispose to medulloblastoma
    • Taylor MD, Liu L, Raffel C, et al: Mutations in SUFU predispose to medulloblastoma. Nat Genet 31:306-310, 2002
    • (2002) Nat Genet , vol.31 , pp. 306-310
    • Taylor, M.D.1    Liu, L.2    Raffel, C.3
  • 19
    • 33846406366 scopus 로고    scopus 로고
    • Radiation-induced brain tumours in nevoid basal cell carcinoma syndrome: Implications for treatment and surveillance
    • Choudry Q, Patel HC, Gurusinghe NT, et al: Radiation-induced brain tumours in nevoid basal cell carcinoma syndrome: Implications for treatment and surveillance. Childs Nerv Syst 23:133-136, 2007
    • (2007) Childs Nerv Syst , vol.23 , pp. 133-136
    • Choudry, Q.1    Patel, H.C.2    Gurusinghe, N.T.3
  • 20
    • 84863979877 scopus 로고    scopus 로고
    • High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age
    • Brugiéres L, Remenieras A, Pierron G, et al: High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. J Clin Oncol 30:2087-2093, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 2087-2093
    • Brugiéres, L.1    Remenieras, A.2    Pierron, G.3
  • 21
    • 79958127479 scopus 로고    scopus 로고
    • Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma
    • Slade I, Murray A, Hanks S, et al: Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Fam Cancer 10:337-342, 2011
    • (2011) Fam Cancer , vol.10 , pp. 337-342
    • Slade, I.1    Murray, A.2    Hanks, S.3
  • 22
    • 84896096387 scopus 로고    scopus 로고
    • Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition
    • Kool M, Jones DT, Jäger N, et al: Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25:393-405, 2014
    • (2014) Cancer Cell , vol.25 , pp. 393-405
    • Kool, M.1    Jones, D.T.2    Jäger, N.3
  • 23
    • 79954444747 scopus 로고    scopus 로고
    • Medulloblastoma: Clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
    • Ellison DW, Dalton J, Kocak M, et al: Medulloblastoma: Clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121:381-396, 2011
    • (2011) Acta Neuropathol , vol.121 , pp. 381-396
    • Ellison, D.W.1    Dalton, J.2    Kocak, M.3
  • 24
    • 84864444165 scopus 로고    scopus 로고
    • Novel mutations target distinct subgroups of medulloblastoma
    • Robinson G, Parker M, Kranenburg TA, et al: Novel mutations target distinct subgroups of medulloblastoma. Nature 488:43-48, 2012
    • (2012) Nature , vol.488 , pp. 43-48
    • Robinson, G.1    Parker, M.2    Kranenburg, T.A.3
  • 25
    • 84903817160 scopus 로고    scopus 로고
    • Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
    • Pietsch T, Schmidt R, Remke M, et al: Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol 128:137-149, 2014
    • (2014) Acta Neuropathol , vol.128 , pp. 137-149
    • Pietsch, T.1    Schmidt, R.2    Remke, M.3
  • 26
    • 67649869544 scopus 로고    scopus 로고
    • Identification of a SUFU germline mutation in a family with Gorlin syndrome
    • Pastorino L, Ghiorzo P, Nasti S, et al: Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A 149A:1539-1543, 2009
    • (2009) Am J Med Genet A , vol.149 A , pp. 1539-1543
    • Pastorino, L.1    Ghiorzo, P.2    Nasti, S.3
  • 27
    • 79957880221 scopus 로고
    • Nevoid basal cell carcinoma syndrome
    • Pagon RA, Adam MP, Ardinger HH, et al (eds): Seattle, WA, University of Washington
    • Evans DG, Farndon PA: Nevoid basal cell carcinoma syndrome, in Pagon RA, Adam MP, Ardinger HH, et al (eds): GeneReviews. Seattle, WA, University of Washington, 1993-2014
    • (1993) GeneReviews
    • Evans, D.G.1    Farndon, P.A.2
  • 28
    • 84882287372 scopus 로고    scopus 로고
    • Molecular pathogenesis of keratocystic odontogenic tumors developing in nevoid basal cell carcinoma syndrome
    • Suzuki M, Nagao K, Hatsuse H, et al: Molecular pathogenesis of keratocystic odontogenic tumors developing in nevoid basal cell carcinoma syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol 116:348-353, 2013
    • (2013) Oral Surg Oral Med Oral Pathol Oral Radiol , vol.116 , pp. 348-353
    • Suzuki, M.1    Nagao, K.2    Hatsuse, H.3
  • 29
    • 84866100107 scopus 로고    scopus 로고
    • Loss of SUFU function in familial multiple meningioma
    • Aavikko M, Li SP, Saarinen S, et al: Loss of SUFU function in familial multiple meningioma. Am J Hum Genet 91:520-526, 2012
    • (2012) Am J Hum Genet , vol.91 , pp. 520-526
    • Aavikko, M.1    Li, S.P.2    Saarinen, S.3
  • 30
    • 84861876867 scopus 로고    scopus 로고
    • Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome
    • Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al: Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 366:2180-2188, 2012
    • (2012) N Engl J Med , vol.366 , pp. 2180-2188
    • Tang, J.Y.1    Mackay-Wiggan, J.M.2    Aszterbaum, M.3
  • 31
    • 84888082077 scopus 로고    scopus 로고
    • Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: A Pediatric Brain Tumor Consortium study
    • Gajjar A, Stewart CF, Ellison DW, et al: Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: A Pediatric Brain Tumor Consortium study. Clin Cancer Res 19:6305-6312, 2013
    • (2013) Clin Cancer Res , vol.19 , pp. 6305-6312
    • Gajjar, A.1    Stewart, C.F.2    Ellison, D.W.3
  • 32
    • 79954611501 scopus 로고    scopus 로고
    • Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors
    • LoRusso PM, Rudin CM, Reddy JC, et al: Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res 17:2502-2511, 2011
    • (2011) Clin Cancer Res , vol.17 , pp. 2502-2511
    • LoRusso, P.M.1    Rudin, C.M.2    Reddy, J.C.3
  • 33
    • 84875960871 scopus 로고    scopus 로고
    • Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma
    • Asklund T, Henriksson R, Axelsson J, et al: Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma. Acta Oncol 52:862-866, 2013
    • (2013) Acta Oncol , vol.52 , pp. 862-866
    • Asklund, T.1    Henriksson, R.2    Axelsson, J.3
  • 34
    • 84877605428 scopus 로고    scopus 로고
    • A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors
    • abstr 9519
    • Geoerger B, Aerts I, Casanova M, et al: A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors. J Clin Oncol 30:610s, 2012 (suppl; abstr 9519)
    • (2012) J Clin Oncol , vol.30 , pp. 610s
    • Geoerger, B.1    Aerts, I.2    Casanova, M.3
  • 35
    • 84872417679 scopus 로고    scopus 로고
    • Itraconazole and arsenic trioxide inhibit hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists
    • Kim J, Aftab BT, Tang JY, et al: Itraconazole and arsenic trioxide inhibit hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell 23:23-34, 2013
    • (2013) Cancer Cell , vol.23 , pp. 23-34
    • Kim, J.1    Aftab, B.T.2    Tang, J.Y.3
  • 36
    • 84865427746 scopus 로고    scopus 로고
    • Alltrans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
    • quiz 1752
    • Iland HJ, Bradstock K, Supple SG, et al: Alltrans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood 120:1570-1580, 2012; quiz 1752
    • (2012) Blood , vol.120 , pp. 1570-1580
    • Iland, H.J.1    Bradstock, K.2    Supple, S.G.3
  • 37
    • 84892940228 scopus 로고    scopus 로고
    • Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: A multicenter randomized controlled trial
    • Zhu HH, Wu DP, Jin J, et al: Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: A multicenter randomized controlled trial. J Clin Oncol 31:4215-4221, 2013
    • (2013) J Clin Oncol , vol.31 , pp. 4215-4221
    • Zhu, H.H.1    Wu, D.P.2    Jin, J.3
  • 38
    • 84878269566 scopus 로고    scopus 로고
    • A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood
    • Cohen KJ, Gibbs IC, Fisher PG, et al: A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro Oncol 15:783-787, 2013
    • (2013) Neuro Oncol , vol.15 , pp. 783-787
    • Cohen, K.J.1    Gibbs, I.C.2    Fisher, P.G.3
  • 39
    • 81155159643 scopus 로고    scopus 로고
    • Consensus statement from the first International Colloquium on Basal Cell Nevus Syndrome (BCNS)
    • Bree AF, Shah MR: Consensus statement from the first International Colloquium on Basal Cell Nevus Syndrome (BCNS). Am J Med Genet A 155A:2091-2097, 2011
    • (2011) Am J Med Genet A , vol.155 A , pp. 2091-2097
    • Bree, A.F.1    Shah, M.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.